The Sweet's Price for Edenville and Other Stories of Black Gay Males consists of eight short stories about black gay males in the Southeastern United States and the ways they try to define their sexuality within a culture that can love them just as much as it can attempt to conscript them in a narrow definition of blackness and manhood in a long war against racism. Often the first casualty is the heart. From the very young who may not know the word "gay" to the older who may run from that same word or try to define themselves within it, each is trying to make a space for an authentic expression of their humanity in loving and sometimes hostile personal worlds.

In this follow-up volume in the Black Fire—This Time series, over seventy-five poets and writers come together on the ongoing theme of "Black is Beautiful, Black is Powerful, Black is Home." Works ranging from poetry, fiction, essays, and drama cover a wide range of Black literature. This "continuum" of writing, as coined by Volume 1 editor Kim McMillon, brings together legends of the Black Arts era with contemporary writers in the tradition. This edition includes a hallmark work from the Black Arts era, We Own the Night by playwright and one of the last living legends Jimmy Garrett. Volume 2 of Black Fire—This Time will educate and inspire the next generation.

The inside story of a band of entrepreneurial upstarts who made millions selling painkillers—until their scheme unraveled, putting them at the center of a landmark criminal trial. • SOON TO BE THE MAJOR MOTION PICTURE PAIN HUSTLERS STARRING EMILY BLUNT AND CHRIS EVANS "Unfolds with the velocity and verve of a Scorsese film…A tour de force."—Patrick Radden Keefe, New York Times bestselling author of Empire of Pain and Say Nothing John Kapoor had already amassed a small fortune in pharmaceuticals when he founded Insys Therapeutics. It was the early 2000s, a boom time for painkillers, and he developed a novel formulation of fentanyl, the most potent opioid on the market. Kapoor, a brilliant immigrant scientist with relentless business instincts, was eager to make the most of his innovation. He gathered around him an ambitious group of young lieutenants. His head of sales—an unstable and unmanageable leader, but a genius of persuasion—built a team willing to pull every lever to close a sale, going so far as to recruit an exotic dancer ready to scrape her way up. They zeroed in on the eccentric and suspect doctors receptive to their methods. Employees at headquarters did their part by deceiving insurance companies. The drug was a niche product, approved only for cancer patients in dire condition, but the company’s leadership pushed it more widely, and together they turned Insys into a Wall Street sensation. But several insiders reached their breaking point and blew the whistle. They sparked a sprawling investigation that would lead to a dramatic courtroom battle, breaking new ground in the government’s fight to hold the drug industry accountable in the spread of addictive opioids. In The Hard Sell, National Magazine Award–finalist Evan Hughes lays bare the pharma playbook. He draws on unprecedented access to insiders of the Insys saga, from top executives to foot soldiers, from the patients and staff of far-flung clinics to the Boston investigators who treated the case as a drug-trafficking conspiracy, flipping cooperators and closing in on the key players. With colorful characters and true suspense, The Hard Sell offers a bracing look not just at Insys, but at how opioids are sold at the point they first enter the national bloodstream—in the doctor’s office.